Learn about the impact of HRD on cancer development, how HRD status may predict sensitivity to certain treatments, and the different HRD testing methods available.
Targeting homologous recombination deficiency (HRD) in cancer research
read more
cancer research
US Cancer Moonshot Plan to Cut Cancer Death Rate in Half
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
Staying a step ahead of breast cancer with data-driven medicine
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could greatly benefit from earlier detection. Today, we know that age alone is not enough to accurately estimate breast cancer risk.
NGS cancer research in the time of COVID-19
The medical research community has been buried in data since well before the global COVID-19 pandemic. How they’re now managing the extreme additional influx of SARS-CoV-2 data determines the outcomes of a lab’s overall research capabilities.
Celebrating small wins: Honoring National Cancer Survivor Month
You never know when life is going to throw you a curve ball. You can plan for something to happen down to the dotted line, but a simple phone call can change your whole perspective on life.